Betahistine is an anti-vertigo medication commonly prescribed for balance disorders or to alleviate vertigo symptoms. It is a histamine analog and H1 receptor agonist, functioning as a vasodilator.
Betahistine is primarily used in the treatment of Ménière’s disease and vascular headaches, though it may exacerbate conditions like bronchial asthma and peptic ulcers.
The drug is also being investigated for other conditions, including obesity associated with Prader-Willi syndrome and attention deficit hyperactivity disorder (ADHD). Common side effects include headache, nausea, and hypersensitivity reactions. Betahistine acts as a weak H3 receptor antagonist and partial H1 receptor agonist, modulating neurotransmitter release and improving blood flow in the inner ear.
The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.
| Other Names | Vasomotal |
|---|---|
| CAS | N-methyl-2-pyridin-2-ylethanamine |
| Molecular Weight | 5638-76-6 |
| Molecular Formula | 136.19 |